These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting. Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759 [TBL] [Abstract][Full Text] [Related]
7. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049 [TBL] [Abstract][Full Text] [Related]
8. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. Khorram O; Laughlin GA; Yen SS J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536 [TBL] [Abstract][Full Text] [Related]
9. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients. Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479 [TBL] [Abstract][Full Text] [Related]
10. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids]. Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670 [TBL] [Abstract][Full Text] [Related]
11. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385 [TBL] [Abstract][Full Text] [Related]
12. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation. Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864 [TBL] [Abstract][Full Text] [Related]
13. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age. van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954 [TBL] [Abstract][Full Text] [Related]
14. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380 [TBL] [Abstract][Full Text] [Related]
15. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. de Groof F; Joosten KF; Janssen JA; de Kleijn ED; Hazelzet JA; Hop WC; Uitterlinden P; van Doorn J; Hokken-Koelega AC J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211 [TBL] [Abstract][Full Text] [Related]
16. Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels. Schmid C; Bianda T; Zwimpfer C; Zapf J; Wiesli P Growth Horm IGF Res; 2005 Aug; 15(4):300-3. PubMed ID: 16054413 [TBL] [Abstract][Full Text] [Related]
17. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement. Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104 [TBL] [Abstract][Full Text] [Related]
18. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530 [TBL] [Abstract][Full Text] [Related]
19. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453 [TBL] [Abstract][Full Text] [Related]
20. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. Chapman IM; Hartman ML; Pieper KS; Skiles EH; Pezzoli SS; Hintz RL; Thorner MO J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]